WESTLAKE CHEMICAL ($WLK) posted quarterly earnings results for Q4 2025 on Tuesday, February 24th. The company reported earnings of -$0.25 per share, beating estimates of -$1.44 by $1.19. The company also reported revenue of $2,533,000,000, missing estimates of $2,630,356,200 by $-97,356,200.
You can see Quiver Quantitative's $WLK stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
WESTLAKE CHEMICAL Insider Trading Activity
WESTLAKE CHEMICAL insiders have traded $WLK stock on the open market 3 times in the past 6 months. Of those trades, 0 have been purchases and 3 have been sales.
Here’s a breakdown of recent trading of $WLK stock by insiders over the last 6 months:
- ALBERT CHAO (Executive Chairman) has made 0 purchases and 3 sales selling 40,836 shares for an estimated $3,004,373.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
WESTLAKE CHEMICAL Hedge Fund Activity
We have seen 152 institutional investors add shares of WESTLAKE CHEMICAL stock to their portfolio, and 223 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- WELLINGTON MANAGEMENT GROUP LLP added 4,163,207 shares (+7239.1%) to their portfolio in Q4 2025, for an estimated $307,827,525
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 2,744,388 shares (-74.8%) from their portfolio in Q4 2025, for an estimated $202,920,048
- CAPITAL WORLD INVESTORS added 2,171,324 shares (+inf%) to their portfolio in Q4 2025, for an estimated $160,547,696
- VICTORY CAPITAL MANAGEMENT INC removed 1,752,541 shares (-61.1%) from their portfolio in Q4 2025, for an estimated $129,582,881
- NORGES BANK removed 1,192,488 shares (-86.8%) from their portfolio in Q4 2025, for an estimated $88,172,562
- CITADEL ADVISORS LLC removed 997,548 shares (-83.1%) from their portfolio in Q4 2025, for an estimated $73,758,699
- DIMENSIONAL FUND ADVISORS LP added 585,438 shares (+45.0%) to their portfolio in Q4 2025, for an estimated $43,287,285
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
WESTLAKE CHEMICAL Analyst Ratings
Wall Street analysts have issued reports on $WLK in the last several months. We have seen 5 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Citigroup issued a "Buy" rating on 01/13/2026
- Mizuho issued a "Outperform" rating on 01/08/2026
- B of A Securities issued a "Buy" rating on 11/03/2025
- UBS issued a "Buy" rating on 10/31/2025
- Truist Securities issued a "Buy" rating on 10/13/2025
To track analyst ratings and price targets for WESTLAKE CHEMICAL, check out Quiver Quantitative's $WLK forecast page.
WESTLAKE CHEMICAL Price Targets
Multiple analysts have issued price targets for $WLK recently. We have seen 10 analysts offer price targets for $WLK in the last 6 months, with a median target of $85.5.
Here are some recent targets:
- John Roberts from Mizuho set a target price of $88.0 on 02/09/2026
- Peter Osterland from Truist Securities set a target price of $99.0 on 01/21/2026
- Patrick Cunningham from Citigroup set a target price of $100.0 on 01/13/2026
- Joshua Spector from UBS set a target price of $92.0 on 12/23/2025
- Bhavesh Lodaya from BMO Capital set a target price of $83.0 on 11/04/2025
- Arun Viswanathan from RBC Capital set a target price of $79.0 on 11/03/2025
- Duffy Fischer from Goldman Sachs set a target price of $78.0 on 11/03/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
